Indiana University School Of Medicine
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1903-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.medicine.iu.edu
Chromoendoscopy for Ulcerative Colitis Surveillance
Completed
- Conditions
- Crohn's DiseaseUlcerative Colitis
- Interventions
- Procedure: Chromoendoscopy with magnification
- First Posted Date
- 2006-01-10
- Last Posted Date
- 2011-11-22
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 100
- Registration Number
- NCT00274209
- Locations
- 🇺🇸
Indiana University Medical Center, Indianapolis, Indiana, United States
The Effects of Obesity and Protein Intake on the Kidney
Not Applicable
Completed
- Conditions
- Kidney Diseases
- Interventions
- Behavioral: Diet
- First Posted Date
- 2005-10-27
- Last Posted Date
- 2015-08-28
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 50
- Registration Number
- NCT00244790
- Locations
- 🇺🇸
University Hospital, Indianapolis, Indiana, United States
Dose Escalation Study for Primary Hepatocellular Carcinoma
Not Applicable
Completed
- Conditions
- Carcinoma, Hepatocellular
- Interventions
- Radiation: Stereotactic Body Radiation
- First Posted Date
- 2005-10-25
- Last Posted Date
- 2018-12-13
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 77
- Registration Number
- NCT00243841
- Locations
- 🇺🇸
Indiana University Department of Radiation Oncology, Indianapolis, Indiana, United States
Pilot Study Using Neoadj Chemo-Rad & EGFR-tyrosine Kinase Inhibitor for Potentially Resectable Pancreatic Cancer
Phase 1
Completed
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2005-10-25
- Last Posted Date
- 2014-03-18
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 8
- Registration Number
- NCT00243854
- Locations
- 🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States
A Feasibility Study of Smoking Cessation Program in Radiation Oncology
Not Applicable
Completed
- Conditions
- Cancer and Tobacco Abuse
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2007-10-31
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 36
- Registration Number
- NCT00236288
- Locations
- 🇺🇸
Indiana University, Department of Radiation Oncology, Indianapolis, Indiana, United States
Effects of RG1068 (Secretin) on Information Processing in Schizophrenia
Phase 2
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2005-10-10
- Last Posted Date
- 2017-03-03
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 30
- Registration Number
- NCT00235274
- Locations
- 🇺🇸
LaRue Carter Hospital, Indianapolis, Indiana, United States
The Role of Serotonin in Hot Flashes After Breast Cancer
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Dietary Supplement: Acute tryptophan depletionDietary Supplement: Half-strength tryptophan depletion (Control)
- First Posted Date
- 2005-09-29
- Last Posted Date
- 2015-04-14
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 28
- Registration Number
- NCT00228943
- Locations
- 🇺🇸
Indiana University Cancer Center, Indianapolis, Indiana, United States
Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia
Phase 3
Terminated
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2013-03-26
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 126
- Registration Number
- NCT00216281
- Locations
- 🇺🇸
LaRue Carter Hospital, Indianapolis, Indiana, United States
Safety Study of the Drug RG1068 in Patients With Obsessive Compulsive Disorder
Phase 2
Completed
- Conditions
- Obsessive Compulsive Disorder (OCD)
- Interventions
- Drug: RG1068 (Synthetic Human Secretin)
- First Posted Date
- 2005-09-22
- Last Posted Date
- 2024-02-23
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 12
- Registration Number
- NCT00216294
- Locations
- 🇺🇸
LaRue Carter Hospital, Indianapolis, Indiana, United States
A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
Phase 2
Completed
- Conditions
- Pervasive Developmental DisorderAsperger's Disorder
- Interventions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2014-06-04
- Lead Sponsor
- Indiana University School of Medicine
- Target Recruit Count
- 25
- Registration Number
- NCT00198055
- Locations
- 🇺🇸
Riley Hospital, Riley Child and Adolescent Psychiatry Clinic, Indianapolis, Indiana, United States
© Copyright 2025. All Rights Reserved by MedPath